Back
Kiniksa Pharmaceuticals Stock Price Chart
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Buy
67
KNSA
Kiniksa Pharmaceuticals
Last Price:
19.39
Seasonality Move:
4.08%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KNSA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Kiniksa Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.79 | Buy |
| 20-day SMA: | 17.65 | Buy |
| 50-day SMA: | 19.18 | Sell |
| 200-day SMA: | 17.77 | Buy |
| 8-day EMA: | 18 | Buy |
| 20-day EMA: | 18.03 | Buy |
| 50-day EMA: | 18.54 | Buy |
| 200-day EMA: | 17.56 | Buy |
Kiniksa Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 57.11 | Buy |
| Chaikin Money Flow: | 286189 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.12 - 18.98) | Buy |
| Bollinger Bands (100): | (17.69 - 20.03) | Sell |
Kiniksa Pharmaceuticals Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kiniksa Pharmaceuticals Stock
Is Kiniksa Pharmaceuticals Stock a Buy?
- Kiniksa Pharmaceuticals share price is 18.71 while KNSA 8-day simple moving average is 17.79, which is a Buy signal.
- The stock price of KNSA is 18.71 while Kiniksa Pharmaceuticals 20-day SMA is 17.65, which makes it a Buy.
- Kiniksa Pharmaceuticals 50-day simple moving average is 19.18 while KNSA share price is 18.71, making it a Sell technically.
- KNSA stock price is 18.71 and Kiniksa Pharmaceuticals 200-day simple moving average is 17.77, creating a Buy signal.
KNSA Technical Analysis vs Fundamental Analysis
Buy
67
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals a Buy or a Sell?
-
Kiniksa Pharmaceuticals stock is rated a Buy
The current Kiniksa Pharmaceuticals [KNSA] share price is $18.71. The Score for KNSA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Kiniksa Pharmaceuticals Stock Info
Market Cap:
1.33B
Price in USD:
18.71
Share Volume:
518.57K
Kiniksa Pharmaceuticals 52-Week Range
52-Week High:
22.09
52-Week Low:
11.01
Buy
67
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Kiniksa Pharmaceuticals Share Price Forecast
-
What is the Kiniksa Pharmaceuticals stock price today?
The Kiniksa Pharmaceuticals stock price is 18.71 USD today. -
Will KNSA stock go up or go down?
Kiniksa Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Kiniksa Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kiniksa Pharmaceuticals is not overvalued.
Is Kiniksa Pharmaceuticals Stock a Buy?
- Kiniksa Pharmaceuticals share price is 18.71 while KNSA 8-day exponential moving average is 18.00, which is a Buy signal.
- The stock price of KNSA is 18.71 while Kiniksa Pharmaceuticals 20-day EMA is 18.03, which makes it a Buy.
- Kiniksa Pharmaceuticals 50-day exponential moving average is 18.54 while KNSA share price is 18.71, making it a Buy technically.
- KNSA stock price is 18.71 and Kiniksa Pharmaceuticals 200-day simple moving average is 17.56, creating a Buy signal.
Fundamental Analysis of Kiniksa Pharmaceuticals
Is Kiniksa Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.23 per share.
Technical Analysis of Kiniksa Pharmaceuticals
Should I short Kiniksa Pharmaceuticals stock?
- KNSA Moving Average Covergence Divergence (MACD) indicator is -0.26, suggesting Kiniksa Pharmaceuticals is a Sell
- Kiniksa Pharmaceuticals Relative Strength Index (RSI) is 57.11, which suggest Kiniksa Pharmaceuticals is overbought
- The Bollinger Bands (25) for Kiniksa Pharmaceuticals is (17.12 - 18.98), which suggest Kiniksa Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Kiniksa Pharmaceuticals is (17.69 - 20.03), which suggest Kiniksa Pharmaceuticals is a Sell
* Kiniksa Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.